Biocardia Inc (BCDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,421 | 949 | 1,103 | 1,835 | 4,305 |
| Receivables | 10 | 58 | 63 | 104 | 115 |
| TOTAL | $1,573 | $1,259 | $1,461 | $2,116 | $4,650 |
| Non-Current Assets | |||||
| PPE Net | 61 | 75 | 94 | 114 | 139 |
| Other Non-Current Assets | 1,256 | 1,345 | 1,432 | 1,517 | 1,600 |
| TOTAL | $1,317 | $1,420 | $1,526 | $1,631 | $1,739 |
| Total Assets | $2,890 | $2,679 | $2,987 | $3,747 | $6,389 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,447 | 1,030 | 890 | 507 | 686 |
| Accrued Expenses | 2,266 | 2,696 | 2,385 | 2,502 | 2,257 |
| TOTAL | $4,071 | $4,071 | $3,608 | $3,330 | $3,616 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | N/A | 333 |
| Other Non-Current Liabilities | 780 | 883 | 982 | 1,077 | 1,138 |
| TOTAL | $780 | $883 | $982 | $1,077 | $1,138 |
| Total Liabilities | $4,851 | $4,954 | $4,590 | $4,407 | $4,754 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,124 | 1,821 | 1,783 | 1,442 | 1,442 |
| Common Shares | 2 | 27 | 2 | 22 | 22 |
| Retained earnings | -156,088 | -154,442 | -152,175 | -150,103 | -147,529 |
| TOTAL | $-1,961 | $-2,275 | $-1,603 | $-660 | $1,635 |
| Total Liabilities And Equity | $2,890 | $2,679 | $2,987 | $3,747 | $6,389 |